title: Curative treatment of oesophageal carcinoma: current options and future developments.
abstract: Since the 1980s major advances in surgery, radiotherapy and chemotherapy have established multimodal approaches as curative treatment options for oesophageal cancer. In addition the introduction of functional imaging modalities such as PET-CT created new opportunities for a more adequate patient selection and therapy response assessment.The majority of oesophageal carcinomas are represented by two histologies: squamous cell carcinoma and adenocarcinoma. In recent years an epidemiological shift towards the latter was observed. From a surgical point of view, adenocarcinomas, which are usually located in the distal third of the oesophagus, may be treated with a transhiatal resection, whereas squamous cell carcinomas, which are typically found in the middle and the upper third, require a transthoracic approach. Since overall survival after surgery alone is poor, multimodality approaches have been developed. At least for patients with locally advanced tumors, surgery alone can no longer be advocated as routine treatment. Nowadays, scientific interest is focused on tumor response to induction radiochemotherapy. A neoadjuvant approach includes the early and accurate assessment of clinical response, optimally performed by repeated PET-CT imaging and endoscopic ultrasound, which may permit early adaption of the therapeutic concept. Patients with SCC that show clinical response by PET CT are considered to have a better prognosis, regardless of whether surgery will be performed or not. In non-responding patients salvage surgery improves survival, especially if complete resection is achieved.
authors: Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Ludwig-Maximilians Universität München, Germany. maria.wolf@med.uni-muenchen.de
authors: Maria C
authors: MC
authors: Wolf
authors: Michael
authors: M
authors: Stahl
authors: Bernd J
authors: BJ
authors: Krause
authors: Luigi
authors: L
authors: Bonavina
authors: Christiane
authors: C
authors: Bruns
authors: Claus
authors: C
authors: Belka
authors: Franz
authors: F
authors: Zehentmayr
references: N Engl J Med. 1992 Jun 11;326(24):1593-8
references: 1584260
references: Ann Surg. 2005 Oct;242(4):566-73; discussion 573-5
references: 16192817
references: J Thorac Cardiovasc Surg. 1978 Nov;76(5):643-54
references: 703369
references: Am J Clin Oncol. 2009 Aug;32(4):405-10
references: 19415029
references: N Engl J Med. 1998 Dec 31;339(27):1979-84
references: 9869669
references: Am J Surg. 1998 Jan;175(1):47-51
references: 9445239
references: Surg Endosc. 2002 Feb;16(2):263-6
references: 11967675
references: BMC Med. 2004 Sep 24;2:35
references: 15447788
references: Ann Thorac Surg. 2001 Jul;72(1):306-13
references: 11465217
references: Ann Surg Oncol. 2003 Aug;10(7):754-61
references: 12900366
references: Surg Endosc. 2003 Sep;17(9):1445-50
references: 12811660
references: J Clin Oncol. 2007 Apr 1;25(10):1160-8
references: 17401004
references: Cancer Lett. 1999 Oct 1;144(2):145-51
references: 10529014
references: Radiother Oncol. 2009 Aug;92(2):276-90
references: 19375187
references: J Clin Oncol. 2005 Jul 1;23(19):4330-7
references: 15781882
references: Lancet Oncol. 2007 Sep;8(9):797-805
references: 17693134
references: Am J Epidemiol. 2001 Jan 15;153(2):114-22
references: 11159155
references: J Nucl Med. 2008 Mar;49(3):480-508
references: 18287273
references: Gut. 2004 Jul;53(7):925-30
references: 15194636
references: N Engl J Med. 2002 Nov 21;347(21):1662-9
references: 12444180
references: J Nucl Med. 2009 May;50 Suppl 1:89S-96S
references: 19380406
references: Ann Surg. 2001 Sep;234(3):360-7; discussion 368-9
references: 11524589
references: Lancet Oncol. 2005 Sep;6(9):659-68
references: 16129366
references: Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):579-83
references: 9635705
references: Ann Surg. 2001 Nov;234(5):581-7
references: 11685019
references: J Surg Oncol. 1997 Jul;65(3):171-4
references: 9236925
references: Dig Surg. 2007;24(2):88-95
references: 17446703
references: N Engl J Med. 2003 Nov 27;349(22):2117-27
references: 14645640
references: N Engl J Med. 1996 Aug 15;335(7):462-7
references: 8672151
references: J Clin Oncol. 2005 Apr 1;23(10):2310-7
references: 15800321
references: J Gastrointest Surg. 2005 Jul-Aug;9(6):794-802
references: 16187480
references: Ann Surg. 2007 Dec;246(6):992-1000; discussion 1000-1
references: 18043101
references: J Clin Oncol. 2008 Mar 1;26(7):1086-92
references: 18309943
references: Chirurg. 1991 Apr;62(4):276-83
references: 1830543
references: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002092
references: 16437440
references: Am J Surg. 2003 Jun;185(6):538-43
references: 12781882
references: Ann Surg. 2003 Oct;238(4):486-94; discussion 494-5
references: 14530720
references: Br J Surg. 1998 Jun;85(6):840-4
references: 9667720
references: J Surg Res. 2004 Mar;117(1):52-7
references: 15013714
references: JAMA. 1999 May 5;281(17):1623-7
references: 10235156
references: Lancet Oncol. 2007 Jun;8(6):545-53
references: 17540306
references: J R Coll Surg Edinb. 1992 Feb;37(1):7-11
references: 1573620
references: Br J Cancer. 2008 Feb 12;98(3):547-57
references: 18212745
references: J Am Coll Surg. 2006 Jul;203(1):7-16
references: 16798482
references: Surg Laparosc Endosc. 1995 Feb;5(1):1-5
references: 7735533
references: Lancet Oncol. 2007 Mar;8(3):226-34
references: 17329193
references: BMC Surg. 2011 Jan 12;11:2
references: 21226918
references: Chirurg. 2005 Nov;76(11):1033-43
references: 16228234
references: Surgery. 2005 Feb;137(2):172-7
references: 15674197
references: Dis Esophagus. 2003;16(2):90-3
references: 12823204
references: J Clin Oncol. 2002 Mar 1;20(5):1167-74
references: 11870157
references: J Laparoendosc Adv Surg Tech A. 2004 Feb;14(1):13-6
references: 15035838